Evaluation of heteroresistance to polymyxin B among carbapenem-susceptible and-resistant Pseudomonas aeruginosa

Journal of Medical Microbiology

Volumn 62, Issue PART8, 2013, Pages 1184-1189

  Hermes, Djuli M ^a   Pormann Pitt, Caroline ^a   Lutz, Larissa ^b   Teixeira, Aline B ^a   Ribeiro, Vanessa B ^a   Netto, Bárbara ^a   Martins, Andreza F ^c   Zavascki, Alexandre P ^a,d   Barth, Afonso L ^a,d  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c Universidade Metodista de Porto Alegre   (Brazil)

^d HCPA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; BETA LACTAMASE IMP; BETA LACTAMASE NDM1; BETA LACTAMASE SPM1; BETA LACTAMASE VIM1; CARBAPENEM; CEFEPIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; METALLO BETA LACTAMASE; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; SULTAMICILLIN; TIMENTIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATE; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG SCREENING; GROWTH INHIBITION; HUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ANTI-BACTERIAL AGENTS; ASCITIC FLUID; BACTEREMIA; BETA-LACTAMASES; BRAZIL; CARBAPENEMS; CYSTIC FIBROSIS; DEMOGRAPHY; DRUG RESISTANCE, BACTERIAL; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; POLYMYXIN B; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SPUTUM;

EID: 84880313308     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.059220-0     Document Type: Article

References (17)

1. Arakawa, Y., Shibata, N., Shibayama, K., Kurokawa, H., Yagi, T., Fujiwara, H. & Goto, M. (2000). Convenient test for screening metallo-b-lactamase-producing gram-negative bacteria by using thiol com-pounds. J Clin Microbiol 38, 40-43.
2. CLSI (2011). Performance Standards for Antimicrobial Susceptibility Testing; Vol. 31, no. 1, 21st Informational Supplement M100-S20. Wayne, PA: Clinical and Laboratory Standards Institute.
3. Hawley, J. S., Murray, C. K. & Jorgensen, J. H. (2008). Colistin heteroresistance in Acinetobacter and its association with previous colistin therapy. Antimicrob Agents Chemother 52, 351-352.
4. Ikonomidis, A., Neou, E., Gogou, V., Vrioni, G., Tsakris, A. & Pournaras, S. (2009). Heteroresistance to meropenem in carbapenem-susceptible Acinetobacter baumannii. J Clin Microbiol 47, 4055-4059.
5. Li, J., Rayner, C. R., Nation, R. L., Owen, R. J., Spelman, D. K., Tan, K. E. & Liolios, L. (2006). Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 50, 2946-2950.
6. Martins, A. F., Zavascki, A. P., Gaspareto, P. B. & Barth, A. L. (2007). Dissemination of Pseudomonas aeruginosa producing SPM-1-like and IMP-1-like metallo-beta-lactamases in hospitals from southern Brazil. Infection 35, 457-460.
7. Monteiro, J., Widen, R. H., Pignatari, A. C., Kubasek, C. & Silbert, S. (2012). Rapid detection of carbapenemase genes by multiplex real-time PCR. J Antimicrob Chemother 67, 906-909.
8. Plipat, N., Livni, G., Bertram, H. & Thomson, R. B., Jr (2005). Unstable vancomycin heteroresistance is common among clinical isolates of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 43, 2494-2496.
9. Poole, K. (2011). Pseudomonas aeruginosa: resistance to the max. Front Microbiol 2, 1-13.
10. Pournaras, S., Ikonomidis, A., Markogiannakis, A., Maniatis, A. N. & Tsakris, A. (2005). Heteroresistance to carbapenems in Acinetobacter baumannii. J Antimicrob Chemother 55, 1055-1056.
11. Pournaras, S., Ikonomidis, A., Markogiannakis, A., Spanakis, N., Maniatis, A. N. & Tsakris, A. (2007). Characterization of clinical isolates of Pseudomonas aeruginosa heterogeneously resistant to carbapenems. J Med Microbiol 56, 66-70.
12. Pournaras, S., Ikonomidis, A., Neou, E., Kantzanou, M., Maniatis, A. N. & Tsakris, A. (2008). Piperacillin/tazobactam-heteroresistant Pseudomonas aeruginosa from urinary infection, successfully treated by piperacillin/tazobactam. J Antimicrob Chemother 61, 757-758.
13. Rinder, H. (2001). Hetero-resistance: an under-recognised con-founder in diagnosis and therapy? J Med Microbiol 50, 1018-1020.
14. Tomasz, A., Nachman, S. & Leaf, H. (1991). Stable classes of phenotypic expression in methicillin-resistant clinical isolates of staphylococci. Antimicrob Agents Chemother 35, 124-129.
15. Yamazumi, T., Pfaller, M. A., Messer, S. A., Houston, A. K., Boyken, L., Hollis, R. J., Furuta, I. & Jones, R. N. (2003). Characterization of heteroresistance to fluconazole among clinical isolates of Cryptococcus neoformans. J Clin Microbiol 41, 267-272.
16. Yau, W., Owen, R. J., Poudyal, A., Bell, J. M., Turnidge, J. D., Yu, H. H., Nation, R. L. & Li, J. (2009). Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme. J Infect 58, 138-144.
17. Zavascki, A. P., Goldani, L. Z., Li, J. & Nation, R. L. (2007). Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review. J Antimicrob Chemother 60, 1206-1215.